Page last updated: 2024-10-28

lidocaine and Carcinoma, Basal Cell

lidocaine has been researched along with Carcinoma, Basal Cell in 7 studies

Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.

Carcinoma, Basal Cell: A malignant skin neoplasm that seldom metastasizes but has potentialities for local invasion and destruction. Clinically it is divided into types: nodular, cicatricial, morphaic, and erythematoid (pagetoid). They develop on hair-bearing skin, most commonly on sun-exposed areas. Approximately 85% are found on the head and neck area and the remaining 15% on the trunk and limbs. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1471)

Research Excerpts

ExcerptRelevanceReference
"5% lidocaine and 1:200,000 epinephrine) injected into digits, comorbid patient conditions, and postoperative complications including ischemia or necrosis."3.75Local anesthesia using buffered 0.5% lidocaine with 1:200,000 epinephrine for tumors of the digits treated with Mohs micrographic surgery. ( Davis, N; Firoz, B; Goldberg, LH, 2009)
"Induction of post-occlusive reactive hyperemia in malignant tumors is therefore a novel investigational approach that could lead to a new adjuvant tool to increase the efficacy of chemotherapy and radiotherapy, respectively through the synchronized temporary increase of tumor perfusion and oxygenation."2.77Post-occlusive reactive hyperemia in basal cell carcinoma and its potential application to improve the efficacy of solid tumor therapies. ( Fourme, E; Guihard, T; Le Masurier, P; Lebas, N; Reyal, J; Vilmer, C, 2012)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19901 (14.29)18.7374
1990's0 (0.00)18.2507
2000's2 (28.57)29.6817
2010's4 (57.14)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, P1
Smith, H1
Vinciullo, C1
Council, ML1
Hruza, GJ1
Firoz, B1
Davis, N1
Goldberg, LH1
Debu, A1
Sleth, JC1
Girard, C1
Bessis, D1
Guillot, B1
Blatière, V1
Reyal, J1
Lebas, N1
Fourme, E1
Guihard, T1
Vilmer, C1
Le Masurier, P1
Haller, JC1
Cairnduff, F1
Slack, G1
Schofield, J1
Whitehurst, C1
Tunstall, R1
Brown, SB1
Roberts, DJ1
Tromovitch, TA1
Stegeman, SJ1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Randomized Trial of Bupivacaine as Adjuvant for Post-operative Pain in Mohs Micrographic Surgery[NCT04362566]Phase 4174 participants (Actual)Interventional2020-07-30Completed
Etude peropératoire de la Perfusion Sanguine Des Carcinomes Basocellulaires Par Imageur Laser Doppler, au Cours de la Manipulation de l'Influx artériel Tumoral - Recherche d'un phénomène d'hyperémie Tumorale Post-occlusive[NCT01455363]12 participants (Actual)Interventional2011-06-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

3 trials available for lidocaine and Carcinoma, Basal Cell

ArticleYear
Bupivacaine as an Adjunct to Lidocaine in Mohs Micrographic Surgery: A Prospective Randomized Controlled Trial.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2018, Volume: 44, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Anesthetics, Local; Bupivacaine; Carcinoma, Basal Cell; Female; Huma

2018
Post-occlusive reactive hyperemia in basal cell carcinoma and its potential application to improve the efficacy of solid tumor therapies.
    The Tohoku journal of experimental medicine, 2012, Volume: 227, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anesthesia; Carcinoma, Basal Cell; Female; Health; Humans; Hyperemia

2012
Routine double treatments of superficial basal cell carcinomas using aminolaevulinic acid-based photodynamic therapy.
    The British journal of dermatology, 2000, Volume: 143, Issue:6

    Topics: Administration, Cutaneous; Aged; Aminolevulinic Acid; Carcinoma, Basal Cell; Follow-Up Studies; Huma

2000

Other Studies

4 other studies available for lidocaine and Carcinoma, Basal Cell

ArticleYear
Commentary on Bupivacaine as an Adjunct to Lidocaine in Mohs Micrographic Surgery.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2018, Volume: 44, Issue:5

    Topics: Bupivacaine; Carcinoma, Basal Cell; Humans; Lidocaine; Mohs Surgery; Skin Neoplasms

2018
Local anesthesia using buffered 0.5% lidocaine with 1:200,000 epinephrine for tumors of the digits treated with Mohs micrographic surgery.
    Journal of the American Academy of Dermatology, 2009, Volume: 61, Issue:4

    Topics: Aged; Aged, 80 and over; Anesthesia, Local; Anesthetics, Local; Carcinoma, Basal Cell; Carcinoma, Sq

2009
The use of subcutaneous infusion tumescent anesthesia in photodynamic therapy pain control.
    Paediatric anaesthesia, 2012, Volume: 22, Issue:6

    Topics: Amides; Anesthesia, Local; Anesthetics, Local; Basal Cell Nevus Syndrome; Carcinoma, Basal Cell; Chi

2012
Microscopically controlled excision of skin tumors.
    Archives of dermatology, 1974, Volume: 110, Issue:2

    Topics: Acetates; Carcinoma, Basal Cell; Cheek; Ear Neoplasms; Epinephrine; Eye Neoplasms; Eyelid Neoplasms;

1974